Rushikesh V Sable (Rushikesh Sable)

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 2

Top Topics

Klebsiella Pneumoniae

Mesenchymal Stem Cells

Top Venues

Molecular cancer research : MCR

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Sitanshu S Singh, Raul Calvo, Anju Kumari, Rushikesh V Sable, Yuhong Fang, Dingyin Tao, Xin Hu, Sarah Gray Castle, Saifun Nahar, Dandan Li, Emily Major, Tino W Sanchez, Rintaro Kato, Xin Xu, Jian Zhou, Liang Liu, Christopher A LeClair, Anton Simeonov, Bolormaa Baljinnyam, Mark J Henderson, Juan Jose Marugan, Rushikesh Sable
Fatty acid derivatization and cyclization of the immunomodulatory peptide RP-182 targeting CD206high macrophages improves anti-tumor activity. Molecular cancer therapeutics (2024)
Dandan Li, Anne M Miermont, Rushikesh V Sable, Humair S Quadri, Lesley Mathews Griner, Scott E Martin, Taivan Odzorig, Soumita De, Marc Ferrer, Astin S Powers, Stephen M Hewitt, Rushikesh Sable
Scaffolding protein connector enhancer of kinase suppressor of Ras 1 (CNKSR1) regulates MAPK inhibition responsiveness in pancreas cancer via crosstalk with AKT signaling. Molecular cancer research : MCR (2023)